DUBLIN--(BUSINESS WIRE)--The "SNP Genotyping Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The global SNP genotyping market is expected to register a CAGR of 21% during the forecast period.
The analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, among others.
Companies Mentioned
Key Market Trends
Pharmacogenomics Led the End-user Segment of the SNP Genotyping Market
Under end users, pharmacogenomics is the leading segment. The large share of pharmacogenomics is primarily due to the increasing pipeline for personalized medicine and novel drug delivery systems, which are extensively exploiting SNP in genetic materials for drug development applications. According to the Journal of Personalized Medicine, up to June 2019, there were around 132 pharmacogenimic guidelines for the available drugs and also, pharmacogenomic information is added in around 309 medication label. Hence, the growing demand for pharmacogenomics is expected to propel the SNP Genotyping market in this segment.
North America had Largest Share in the Global SNP Market, while Asia-Pacific is the Fastest-growing Region
North America is the dominating region in the SNP genotyping market, due to rising commercial research in personalized medicines and animal breeding, among others. In addition, Asia-Pacific is the fastest-growing market, due to the rising demand for SNP genotyping in emerging economies like China and India, across different fields, which is largely propelling the market's growth.
Key Topics Covered:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Miniaturisation of Equipment and Instruments
4.2.2 Increased Multiplexing Capacity Leading to Increased Application
4.3 Market Restraints
4.3.1 Lack of Standardisation in SNP Processes
4.3.2 Privacy Concerns Pose a Threat to Broad Technology Adoption
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 Technology
5.1.1 TaqMan SNP Genotyping
5.1.2 Massarray SNP Genotyping
5.1.3 SNP GeneChip Arrays
5.1.4 Other Technologies
5.2 End User
5.2.1 Pharmacogenomics
5.2.2 Diagnostic Field
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Danaher Corporation
6.1.4 Douglas Scientific LLC
6.1.5 Illumina Inc.
6.1.6 Life Technologies Corp.
6.1.7 Luminex Corp.
6.1.8 Promega Corporation
6.1.9 Thermo Fischer Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/s2295f
Follow this link:
- Panicked Elon Musk Reportedly Begging Engineers Not to Leave - November 20th, 2022
- NASA Drops Stunning New James Webb Image of a Star Being Born - November 20th, 2022
- Elon Musk Locks Twitter Employees Out Office, Then Asks Them to Meet Him on the 10th Floor - November 20th, 2022
- Former Facebook Exec Says Zuckerberg Has Surrounded Himself With Sycophants - November 20th, 2022
- NASA Orders Press Not to Photograph Launch Site After Moon Mission Takes Off - November 20th, 2022
- FDA Gives First Go Ahead for Lab Grown Meat Product - November 20th, 2022
- "Elon" Plummets in Popularity as a Baby Name for Some Reason - November 20th, 2022
- Celebrities' Bored Apes Are Hilariously Worthless Now - November 20th, 2022
- Experts Baffled by Why NASA’s “Red Crew” Wear Blue Shirts - November 20th, 2022
- Sam Bankman-Fried Admits the "Ethics Stuff" Was "Mostly a Front" - November 20th, 2022
- Twitter Claims Video of Moon Rocket Launch Is Revenge Porn - November 20th, 2022
- Ticketmaster May Have Finally Met Its Match: Furious Swifties - November 20th, 2022
- Celebrities Are Officially Being Sued by FTX Retail Investors - November 20th, 2022
- NASA Tells Astronauts That Tweeting Isn't As Important as Staying Alive - November 20th, 2022
- Startup Says It's Building a Giant CO2 Battery in the United States - November 20th, 2022
- Experts Excoriate NASA Report Claiming James Webb Wasn't Homophobic - November 20th, 2022
- Behind the Lawsuit Against Celebs Who Shilled FTX Before Its Spectacular Meltdown - November 20th, 2022
- Amazing Map Lets You Scroll Through the Entire Known Universe - November 20th, 2022
- So Many People Are Using a Diabetes Drug for Weight Loss That Actual Diabetics Are Having Trouble Getting It - November 20th, 2022
- Manslaughter Case Has a Strange Twist: Tesla That Killed Couple Was on Autopilot - November 4th, 2022
- Greta Thunberg Says UN Climate Conference Is a Scam and She's Not Attending - November 4th, 2022
- This Deepfake AI Singing Dolly Parton's "Jolene" Is Worryingly Good - November 4th, 2022
- There's Something Strange About How These Stars Are Moving, Scientists Say - November 4th, 2022
- NASA Sets Launch Date for Mission to $10 Quintillion Asteroid - November 4th, 2022
- Scientists Use Actual Lunar Soil Sample to Create Rocket Fuel - November 4th, 2022
- Scientists Spot "Stripped, Pulsating Core" of Star Caused By Horrific Accident - November 4th, 2022
- Scientists Found a Way to Control How High Mice Got on Cocaine - November 4th, 2022
- Cats May Be Tampering With Crime Scenes, Scientists Say - November 4th, 2022
- Chinese Spaceplane Releases Mystery Object Into Orbit - November 4th, 2022
- Elon Musk Meeting With Advertisers, Begging Them Not to Leave Twitter - November 4th, 2022
- US Gov to Crack Down on "Bossware" That Spies On Employees' Computers - November 4th, 2022
- Huge Drone Swarm to Form Giant Advertisement Over NYC Skyline - November 4th, 2022
- AOC Says Her Twitter Account Broke After She Made Fun of Elon Musk - November 4th, 2022
- China Plans to Send Monkeys to Space Station to Have Sex With Each Other - November 4th, 2022
- Twitter Working on Plan to Charge Users to Watch Videos - November 4th, 2022
- Hackers Just Took Down One of the World's Most Advanced Telescopes - November 4th, 2022
- Jeff Bezos' Housekeeper Says She Had to Climb Out the Window to Use the Bathroom - November 4th, 2022
- That "Research" About How Smartphones Are Causing Deformed Human Bodies Is SEO Spam, You Idiots - November 4th, 2022
- Double Duty: Early Research Reveals how a Single Drug Delivers Twice the Impact in Fragile X - URMC - June 29th, 2022
- New Technology Helps Reveal Inner Workings of Human Genome - Weill Cornell Medicine Newsroom - June 29th, 2022
- HIV drug may improve cognitive function in people with Down syndrome - Study Finds - June 29th, 2022
- Novartis hunting for sickle cell cure with Precision deal - BioPharma Dive - June 29th, 2022
- Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy Experts - Business... - June 29th, 2022
- A Functional Medicine Approach to Detoxing the Body - Magazine of Santa Clarita - June 29th, 2022
- Meet the company trying precision medicine for autism | Spectrum - Spectrum - June 29th, 2022
- CRISPR, 10 Years On: Learning to Rewrite the Code of Life - The New York Times - June 29th, 2022
- After 9 Years in Trials, Roche's Crenezumab Stalls Out - Being Patient - June 29th, 2022
- Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results - GuruFocus.com - June 29th, 2022
- Dr. Stephen Kingsmore to receive Luminary Award at 2022 Precision Medicine World Conference - EurekAlert - June 29th, 2022
- Do agri-businesses 'control' agriculture? The emerging gene-editing revolution in Latin America is challenging that belief - Genetic Literacy Project - June 29th, 2022
- New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos USA - English -... - June 29th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - June 29th, 2022
- Realizing Gene Therapy and Cell Regeneration in Heart Disease - BioSpace - January 25th, 2022
- Small children getting less sick from Omicron; Genetic mutation protects against severe COVID - Reuters - January 25th, 2022
- Bionano Genomics Announces its Support for the AGMG - GlobeNewswire - January 25th, 2022
- Discovery of hundreds of genes potentially associated with ALS may steer scientists toward treatments - Stanford Medical Center Report - January 25th, 2022
- Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology - Business Wire - January 25th, 2022
- EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and... - January 25th, 2022
- Roche revives a closely watched Huntington's disease drug - BioPharma Dive - January 25th, 2022
- WashU part of $65 million NIH study of schizophrenia in young people Washington University School of Medicine in St. Louis - Washington University... - January 25th, 2022
- UTSW researchers take new approach to fight viral infections - UT Southwestern - January 25th, 2022
- Promising ALS therapy moves closer to clinic - EurekAlert - January 25th, 2022
- 5 Slides We're Discussing: Gene therapy and the promise for rare disease - State of Reform - State of Reform - January 25th, 2022
- Worldwide Genomic Cancer Panel and Profiling Industry to 2024 - Next Generation Sequencing Fuels a Revolution - PRNewswire - January 25th, 2022
- Genetic Research Shows Rapid Immune Response in Children Protects Them From COVID-19 - SciTechDaily - January 25th, 2022
- British Labs Supply the World with Genetic Information about COVID-19 - VOA Learning English - January 25th, 2022
- Xenotransplantation and the future of medicine - Hindustan Times - January 25th, 2022
- Which Drugs Will Survive Climate Change? We Investigated. - VICE - January 25th, 2022
- Sema4 : The Positives (and Negatives) of Medical Testing - marketscreener.com - January 25th, 2022
- UC Davis Health's partnership in telegenomics improves accessibility to genetic medicine with telemedicine robots - The Aggie - The Aggie - September 5th, 2021
- Could gene therapies be used to cure more people with HIV? - aidsmap - September 5th, 2021
- What to expect at the FDA's two-day meeting on gene therapy safety - BioPharma Dive - September 5th, 2021
- Global DNA Sequencing Report 2021: There is a Move Toward a More Consumer-Focused Model - Yahoo Finance - September 5th, 2021
- Agathos Biologics Receives $900,000 from the North Dakota Bioscience Innovation Grant Program - Yahoo Finance - September 5th, 2021
- New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many - The Conversation US - September 5th, 2021
- An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and s... - Physician's Weekly - September 5th, 2021
- Intense exercise could trigger ALS in those with genetic risk - Livescience.com - September 5th, 2021
- UT Southwestern selected top health care employer in Texas by Forbes - UT Southwestern - September 5th, 2021
- Opinion: Gene editing can be leveraged for the greater good with appropriate regulations - Varsity - September 5th, 2021
- Beefing up livestock disaster assistance | Farm & Ranch | willistonherald.com - Williston Daily Herald - September 5th, 2021